Antiangiogenic therapy combined with immune checkpoint blockade mediates CCR7+CD8+ T-cell entry into HCC through high endothelial venules.

Journal:

Hepatology

Published:

2025-06-14

DOI:

10.1097/hep.0000000000001426

Affiliations:

8

Authors:

16

Go to article

Institutions	Authors	Share
State Key Laboratory of Oncology in South China, SYSUCC, China	12.000000 12.000000	0.75
MOE Key Laboratory of Gene Function and Regulation, SYSU, China	2.000000	0.13
Harbin Medical University Cancer Hospital, China	1.000000	0.06
Sun Yat-sen University (SYSU), China	1.000000	0.06

Interested in Oncology and Carcinogenesis?